In this study, combining a knockout for CG1847 with the Gal4/UAS binary expression system, we developed and optimised an in vivo system to ‘bioassay’ the pathogenicity of AIP variants found in patients with pituitary tumours.37 The gene discussed is LGALS4; the disease is pituitary tumor.